The global Histology & Cytology market gathered revenue around USD 11.9 Billion in 2020 and market is set to grow USD 27.2 Billion by the end of 2027 and is estimated to expand at a modest CAGR of 10.9% during the prediction period 2021 to 2027.
Growth Factors:
The global prevalence of cancer has been rising significantly, and the disease is considered the second major cause of death after cardiovascular diseases. Various factors contributing to the rise in the prevalence of cancer include urbanization, tobacco smoking, increasing pollution, changing diet patterns, and increase in the post-reproductive life span. According to the National Cancer Institute, over 1,806,600 new cases of cancer are anticipated to be diagnosed in the U.S. in 2020. Cervical cancer poses a significant threat to the female population in developing regions, and hence prevention as well as control of cervical cancer could be possible by early screening and diagnosis. Therefore, early detection of cervical cancer would improve the survival rate and quality of life of the patients, as it can be treated successfully with various treatment modalities. According to the World Health Organization (WHO), most of the cancer cases are detected in the final stage when they are not curable, especially in developing regions.
This research report purposes at stressing the most lucrative growth prospects. The aim of the research report is to provide an inclusive valuation of the Histology & Cytology market and it encompasses thoughtful visions, actualities, industry-validated market findings, historic data, and prognoses by means of appropriate set of assumptions and practice. Global Histology & Cytology market report aids in comprehending market structure and dynamics by recognizing and scrutinizing the market sectors and predicted the global market outlook.
Report Coverage
Report Scope | Details |
Market Size | USD 27.2 Billion by 2027 |
Growth Rate | CAR 10.9% From 2021 to 2027 |
Base Year | 2020 |
Forecast Period | 2021 to 2027 |
Largest Market | North America |
Fastest Growing Market | Asia Pacific |
Segments Covered | Type of Examination, Product, Test Type, End User and Region |
Report coverage | Growth Factors, Revenue Status, Competitive Landscape, and Future Trends |
Companies Mentioned | Abbott, Becton, Dickinson and Company, Danaher, F. Hoffmann-La Roche Ltd., Hologic, Inc., Merck KGaA, PerkinElmer, Inc., Sysmex Corporation, Thermo Fisher Scientific, Inc., and Trivitron Healthcare. |
COVID-19 Impact Assessment on Market Landscape
The report comprises the scrutiny of COVID-19 lock-down impact on the income of market leaders, disrupters and followers. Since lock down was instigated differently in diverse regions and nations, influence of same is also dissimilar across various industry verticals. The research report offers present short-term and long-term influence on the market to assist market participants across value chain makers to formulate the framework for short term and long-lasting tactics for recovery and by region.
Histology & Cytology market Report empowers readers with all-inclusive market intelligence and offers a granular outline of the market they are operational in. Further this research study delivers exceptional combination of tangible perceptions and qualitative scrutiny to aid companies accomplishes sustainable growth. This report employs industry-leading research practices and tools to assemble all-inclusive market studies, intermingled with pertinent data. Additionally, this report also emphases on the competitive examination of crucial players by analyzing their product portfolio, pricing, gross margins, financial position, growth approaches, and regional occurrence.
North America to Dominate Global Market
The global histology & cytology market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global market in 2020, followed by Europe. North America accounted for a major share of the global histology & cytology market in 2020, owing to early adoption of advanced technologies and well-established healthcare infrastructure, and strategies adopted by key players. The histology & cytology market in Asia Pacific is likely to expand at a high CAGR from 2021 to 2027. Rise in prevalence of cancer across the region is projected to accelerate the growth of the market in the region.
Competitive Rivalry
Foremost players in the market are attentive on adopting corporation strategies to enhance their market share. Some of the prominent tactics undertaken by leading market participants in order to sustain the fierce market completion include collaborations, acquisitions, substantial spending in R&D and the improvement of new-fangled products or reforms among others.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
Some of the prominent players in the Histology & Cytology Market include: Abbott, Becton, Dickinson and Company, Danaher, F. Hoffmann-La Roche Ltd., Hologic, Inc., Merck KGaA, PerkinElmer, Inc., Sysmex Corporation, Thermo Fisher Scientific, Inc., and Trivitron Healthcare.
Unravelling the Critical Segments
This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects including product type, application/end-user, and region. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for period 2017 to 2027 and covers subsequent region in its scope:
By Geography
North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)
Highlights of the Report:
Research Methodology
In the study, a unique research methodology is utilized to conduct extensive research on the growth of the Histology & Cytology market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.
Secondary resources referred to by analysts during the production of the Histology & Cytology market study are as follows - statistics from government organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, all of whom have contributed to the development of this report as a primary resource.
Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the market, and makes the projections on the growth prospects of the Histology & Cytology markets more accurate and reliable.
Secondary Research
It involves company databases such as Hoover's: This assists us recognize financial information, structure of the market participants and industry competitive landscape.
The secondary research sources referred in the process are as follows:
Primary Research
Primary research includes face-to face interviews, online surveys, and telephonic interviews.
Industry participants involved in this research study include:
Key Points Covered in Histology & Cytology market Study:
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Histology & Cytology Market, By Type of Examination
7.1. Histology & Cytology Market, by Type of Examination, 2021-2027
7.1.1. Histology
7.1.1.1. Market Revenue and Forecast (2016-2027)
7.1.2. Cytology
7.1.2.1. Market Revenue and Forecast (2016-2027)
Chapter 8. Global Histology & Cytology Market, By Product
8.1. Histology & Cytology Market, by Product, 2021-2027
8.1.1. Instruments & Analysis Software System
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. Consumables & Reagents
8.1.2.1. Market Revenue and Forecast (2016-2027)
Chapter 9. Global Histology & Cytology Market, By Test Type
9.1. Histology & Cytology Market, by Test Type, 2021-2027
9.1.1. Microscopy Methods
9.1.1.1. Market Revenue and Forecast (2016-2027)
9.1.2. Flow Cytometry
9.1.2.1. Market Revenue and Forecast (2016-2027)
9.1.3. Molecular Genetic Methods
9.1.3.1. Market Revenue and Forecast (2016-2027)
Chapter 10.Global Histology & Cytology Market, By End User
10.1. Histology & Cytology Market, by End User, 2021-2027
10.1.1. Hospitals & Clinics
10.1.1.1. Market Revenue and Forecast (2016-2027)
10.1.2. Academic & Research Institutes
10.1.2.1. Market Revenue and Forecast (2016-2027)
10.1.3. Others
10.1.3.1. Market Revenue and Forecast (2016-2027)
Chapter 11.Global Histology & Cytology Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Type of Examination (2016-2027)
11.1.2. Market Revenue and Forecast, by Product (2016-2027)
11.1.3. Market Revenue and Forecast, by Test Type (2016-2027)
11.1.4. Market Revenue and Forecast, by End User (2016-2027)
11.1.5. U.S.
11.1.5.1. Market Revenue and Forecast, by Type of Examination (2016-2027)
11.1.5.2. Market Revenue and Forecast, by Product (2016-2027)
11.1.5.3. Market Revenue and Forecast, by Test Type (2016-2027)
11.1.5.4. Market Revenue and Forecast, by End User (2016-2027)
11.1.6. Rest of North America
11.1.6.1. Market Revenue and Forecast, by Type of Examination (2016-2027)
11.1.6.2. Market Revenue and Forecast, by Product (2016-2027)
11.1.6.3. Market Revenue and Forecast, by Test Type (2016-2027)
11.1.6.4. Market Revenue and Forecast, by End User (2016-2027)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Type of Examination (2016-2027)
11.2.2. Market Revenue and Forecast, by Product (2016-2027)
11.2.3. Market Revenue and Forecast, by Test Type (2016-2027)
11.2.4. Market Revenue and Forecast, by End User (2016-2027)
11.2.5. UK
11.2.5.1. Market Revenue and Forecast, by Type of Examination (2016-2027)
11.2.5.2. Market Revenue and Forecast, by Product (2016-2027)
11.2.5.3. Market Revenue and Forecast, by Test Type (2016-2027)
11.2.5.4. Market Revenue and Forecast, by End User (2016-2027)
11.2.6. Germany
11.2.6.1. Market Revenue and Forecast, by Type of Examination(2016-2027)
11.2.6.2. Market Revenue and Forecast, by Product (2016-2027)
11.2.6.3. Market Revenue and Forecast, by Test Type (2016-2027)
11.2.6.4. Market Revenue and Forecast, by End User (2016-2027)
11.2.7. France
11.2.7.1. Market Revenue and Forecast, by Type of Examination (2016-2027)
11.2.7.2. Market Revenue and Forecast, by Product (2016-2027)
11.2.7.3. Market Revenue and Forecast, by Test Type (2016-2027)
11.2.7.4. Market Revenue and Forecast, by End User (2016-2027)
11.2.8. Rest of Europe
11.2.8.1. Market Revenue and Forecast, by Type of Examination (2016-2027)
11.2.8.2. Market Revenue and Forecast, by Product (2016-2027)
11.2.8.3. Market Revenue and Forecast, by Test Type (2016-2027)
11.2.8.4. Market Revenue and Forecast, by End User (2016-2027)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Type of Examination (2016-2027)
11.3.2. Market Revenue and Forecast, by Product (2016-2027)
11.3.3. Market Revenue and Forecast, by Test Type (2016-2027)
11.3.4. Market Revenue and Forecast, by End User (2016-2027)
11.3.5. India
11.3.5.1. Market Revenue and Forecast, by Type of Examination (2016-2027)
11.3.5.2. Market Revenue and Forecast, by Product (2016-2027)
11.3.5.3. Market Revenue and Forecast, by Test Type (2016-2027)
11.3.5.4. Market Revenue and Forecast, by End User (2016-2027)
11.3.6. China
11.3.6.1. Market Revenue and Forecast, by Type of Examination (2016-2027)
11.3.6.2. Market Revenue and Forecast, by Product (2016-2027)
11.3.6.3. Market Revenue and Forecast, by Test Type (2016-2027)
11.3.6.4. Market Revenue and Forecast, by End User (2016-2027)
11.3.7. Japan
11.3.7.1. Market Revenue and Forecast, by Type of Examination (2016-2027)
11.3.7.2. Market Revenue and Forecast, by Product (2016-2027)
11.3.7.3. Market Revenue and Forecast, by Test Type (2016-2027)
11.3.7.4. Market Revenue and Forecast, by End User (2016-2027)
11.3.8. Rest of APAC
11.3.8.1. Market Revenue and Forecast, by Type of Examination (2016-2027)
11.3.8.2. Market Revenue and Forecast, by Product (2016-2027)
11.3.8.3. Market Revenue and Forecast, by Test Type (2016-2027)
11.3.8.4. Market Revenue and Forecast, by End User (2016-2027)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Type of Examination (2016-2027)
11.4.2. Market Revenue and Forecast, by Product (2016-2027)
11.4.3. Market Revenue and Forecast, by Test Type (2016-2027)
11.4.4. Market Revenue and Forecast, by End User (2016-2027)
11.4.5. GCC
11.4.5.1. Market Revenue and Forecast, by Type of Examination (2016-2027)
11.4.5.2. Market Revenue and Forecast, by Product (2016-2027)
11.4.5.3. Market Revenue and Forecast, by Test Type (2016-2027)
11.4.5.4. Market Revenue and Forecast, by End User (2016-2027)
11.4.6. North Africa
11.4.6.1. Market Revenue and Forecast, by Type of Examination (2016-2027)
11.4.6.2. Market Revenue and Forecast, by Product (2016-2027)
11.4.6.3. Market Revenue and Forecast, by Test Type (2016-2027)
11.4.6.4. Market Revenue and Forecast, by End User (2016-2027)
11.4.7. South Africa
11.4.7.1. Market Revenue and Forecast, by Type of Examination (2016-2027)
11.4.7.2. Market Revenue and Forecast, by Product (2016-2027)
11.4.7.3. Market Revenue and Forecast, by Test Type (2016-2027)
11.4.7.4. Market Revenue and Forecast, by End User (2016-2027)
11.4.8. Rest of MEA
11.4.8.1. Market Revenue and Forecast, by Type of Examination (2016-2027)
11.4.8.2. Market Revenue and Forecast, by Product (2016-2027)
11.4.8.3. Market Revenue and Forecast, by Test Type (2016-2027)
11.4.8.4. Market Revenue and Forecast, by End User (2016-2027)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Type of Examination (2016-2027)
11.5.2. Market Revenue and Forecast, by Product (2016-2027)
11.5.3. Market Revenue and Forecast, by Test Type (2016-2027)
11.5.4. Market Revenue and Forecast, by End User (2016-2027)
11.5.5. Brazil
11.5.5.1. Market Revenue and Forecast, by Type of Examination (2016-2027)
11.5.5.2. Market Revenue and Forecast, by Product (2016-2027)
11.5.5.3. Market Revenue and Forecast, by Test Type (2016-2027)
11.5.5.4. Market Revenue and Forecast, by End User (2016-2027)
11.5.6. Rest of LATAM
11.5.6.1. Market Revenue and Forecast, by Type of Examination (2016-2027)
11.5.6.2. Market Revenue and Forecast, by Product (2016-2027)
11.5.6.3. Market Revenue and Forecast, by Test Type (2016-2027)
11.5.6.4. Market Revenue and Forecast, by End User (2016-2027)
Chapter 12. Company Profiles
12.1. Abbott, Becton
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Dickinson and Company
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Danaher, F. Hoffmann-La Roche Ltd
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Hologic, Inc.
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Merck KGaA
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. PerkinElmer, Inc.
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Sysmex Corporation,
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Thermo Fisher Scientific, Inc
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Trivitron Healthcare.
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms